NEWCARE HEALTH CORP
NT 10-Q, 1998-05-18
SKILLED NURSING CARE FACILITIES
Previous: WELCOME HOME INC, 10-Q, 1998-05-18
Next: CSI COMPUTER SPECIALISTS INC, 10KSB, 1998-05-18



PAGE
<PAGE>
             UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                               FORM 12b-25
                                                               SEC FILE NUMBER
                       NOTIFICATION OF LATE FILING                 0-24110
 
                                FORM 10-Q                       CUSIP NUMBER
                                                                   651053
                     For Period Ended: March 31, 1998

[Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.]

PART I - REGISTRANT INFORMATION

                        NEWCARE HEALTH CORPORATION
                        --------------------------
                          Full Name of Registrant

                              Not Applicable
                         -------------------------
                         Former Name if Applicable

                     6000 Lake Forrest Drive, Suite 315
         --------------------------------------------------------
         Address of Principal Executive Office (Street and Number)

                           Atlanta, Georgia 30328
                          ------------------------
                          City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the Registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate) 

     (a)  The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

     (b)  The subject annual report, semi-annual report, transition report on
          Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
          filed on or before the fifteenth calendar day following the
[X]       prescribed due date; or the subject quarterly report of transition
          report on Form 10-Q, or portion thereof will be filed on or before
          the fifth calendar day following the prescribed due date; and

     (c)  The accountant's statement or other exhibit required by Rule 12b-
          25 has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.

Due to the nature of the Company's business activities, the person responsible
for preparation of the financial information for the Form 10-Q has been out of
town and therefore unable to complete the financials and file the Form 10-Q in
a timely manner.
<PAGE>
PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification.

               Jon D. Sawyer                 303/893-2300
               -------------          -----------------------------
                  (Name)              (Area Code)(Telephone Number)

(2)  Have all other periodic reports required under Section
     13 or 15(d) of the Securities Exchange Act of 1934 or
     Section 30 of the Investment Company Act of 1940 
     during the preceding 12 months (or for such shorter) 
     period that the Registrant was required to file such 
     reports) been filed?  If answer is no, identify report(s). [X]Yes   [ ]No

(3)  Is it anticipated that any significant change in results
     of operations from the corresponding period for the last
     fiscal year will be reflected by the earnings statements
     to be included in the subject report or portion thereof?   [X]Yes   [ ]No

NARRATIVE AND QUALITATIVE EXPLANATION:

The Company expects to report that during the quarter ended March 31, 1998, it
had total operating revenues of approximately $13,651,353 and a loss of
approximately $(1,860,625).  During the quarter ended March 31, 1997, the
Company had total operating revenue of $6,767,718, and a net loss of
$(37,108).

The increase in revenues during the first quarter of 1998 was a result of an
increase in the number of facilities operated by the Company during the year. 
The increased loss was primarily due to increased general and administative
expenses as a result of increased activity surrounding acquisitions, and
included management salaries, related costs, travel expenses, legal and audit
fees, supplies and corporate insurance.

- ------------------------------------------------------------------------------

                       NEWCARE HEALTH CORPORATION
               -------------------------------------------
               (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

                                   NEWCARE HEALTH CORPORATION


Date: May 15, 1998                 By /s/ James H. Sanregret
                                      James H. Sanregret
                                      Chief Financial Officer 

[ATTENTION: Intentional misstatements of omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).]


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission